Solvay Pharmaceuticals

Overview

Solvay Pharmaceuticals, now part of AbbVie, was a prominent player in the pharmaceutical industry known for its innovative therapies across various therapeutic areas. With a strong emphasis on research and development, the company focused on providing solutions for patient care.

Therapeutic areas

API / Drug Master Files

Solvay Pharmaceuticals holds 0 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CHOLECALCIFEROLInactive1999-05-21
• FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN GAInactive1986-11-21
• HORMONE G. FACILITY LOCATED IN BAUDETTE, MINNESOTAInactive1986-06-25
• URSODEOXYCHOLIC ACID (250MG. TABLETS)Inactive1985-05-22
• CHENODEOXYCHOLIC ACIDInactive1974-04-30
• QUALITY CONTROL MANUALInactive1974-01-08
• SODIUM FLUORIDE TABLETS AND CAPSULESInactive1969-05-21
• LITHIUM CITRATE SYRUPInactive1969-02-10
• MANUFACTURING CONTROL INFORMATION FOR--LITHIUM CARBONATEInactive1967-06-27
• GENERAL INFO-DISCN. INVESTIGATIONAL DRUGSInactive1963-03-08
• DUVADILAN (ISOXSUPRINE HCL)Inactive1959-04-13

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Solvay Pharmaceuticals in our records. PharmaTek screens the full directory against live FDA enforcement data.